Reduction of Sympathetic Hyperactivity by Enalapril in Patients with Chronic Renal Failure
Open Access
- 29 April 1999
- journal article
- clinical trial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 340 (17), 1321-1328
- https://doi.org/10.1056/nejm199904293401704
Abstract
Inhibition of angiotensin-converting enzyme (ACE) reduces the risk of cardiovascular problems in patients with chronic renal failure. This effect may be due in part to a decrease in sympathetic nervous activity, but no direct evidence of such an action is available. We studied muscle sympathetic-nerve activity in 14 patients with hypertension, chronic renal failure, and increased plasma renin activity before, during, and after administration of the ACE inhibitor enalapril. Ten other patients with similar clinical characteristics were studied before and during treatment with the calcium-channel blocker amlodipine. Normal subjects matched for age and weight were included in both studies. At base line, mean (±SD) muscle sympathetic-nerve activity was higher in the group of patients who received enalapril than in the control subjects (35±17 vs. 19±9 bursts per minute, P=0.004). The baroreflex curve, which reflects changes in muscle sympathetic-nerve activity caused by manipulations of blood pressure with sodium nitroprusside and phenylephrine, was shifted to the right in the patients, but baroreflex sensitivity was similar to that in the control subjects (–2.1±1.9 and –2.7±1.3 bursts per minute per mm Hg, respectively; P=0.36). A single dose of the sympatholytic drug clonidine caused a greater fall in blood pressure in the patients than in the control subjects. Treatment with enalapril normalized blood pressure and muscle sympathetic-nerve activity (at 23±10 bursts per minute) in the patients and shifted the baroreflex curve to the left, reflecting normal blood-pressure levels, without significantly changing sensitivity (–2.3±1.8 bursts per minute per mm Hg, P=0.96). In the patients who received amlodipine, treatment also lowered blood pressure but increased muscle sympathetic-nerve activity, from 41±19 to 56±14 bursts per minute (P=0.02). Increased sympathetic activity contributes to hypertension in patients with chronic renal disease. ACE inhibition controls hypertension and decreases sympathetic hyperactivity.Keywords
This publication has 32 references indexed in Scilit:
- Renal afferent impulses, the posterior hypothalamus, and hypertension in rats with chronic renal failureKidney International, 1997
- Left ventricular mass is linked to cardiac noradrenaline in normotensive and hypertensive patientsJournal Of Hypertension, 1996
- Enalaprilat augments arterial and cardiopulmonary baroreflex control of sympathetic nerve activity in patients with heart failureJournal of the American College of Cardiology, 1996
- Direct assessment of extracellular water volume by the bromide‐dilution method in growth hormone‐deficient adults*European Journal of Clinical Investigation, 1995
- Divergent Effects of Dihydropyridine and Phenylalkylamine Calcium Channel Antagonist Classes on Autonomic Function in Human HypertensionHypertension, 1995
- Renal Afferent Denervation Prevents Hypertension in Rats With Chronic Renal FailureHypertension, 1995
- Elevated sympathetic nerve activity in patients with accelerated essential hypertension.JCI Insight, 1993
- Sympathomoderating influence of benazepril in essential hypertensionJournal Of Hypertension, 1992
- Elevated sympathetic nerve activity in borderline hypertensive humans. Evidence from direct intraneural recordings.Hypertension, 1989
- Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart FailureNew England Journal of Medicine, 1984